title: [What's new in vaccines against herpes simplex infections?].
abstract: Herpes simplex viruses (HSV) can cause a variety of infections, including genital herpes. Despite effective antiviral therapy HSV infections remain a public health problem. Vaccines offer the possibility for controlling the spread and limiting HSV disease, two strategies for herpes vaccination: prophylactic immunization or therapeutic immunization. The article discusses the results of different studies, in particular, concerning recombinant vaccines, DISC vaccines and DNA vaccines.
authors.affiliation: Département pluridisciplinaire de Médecine, CHU Grenoble, 38043 Grenoble, France.
authors.forename: A
authors.initials: A
authors.lastname: Bosseray
authors.forename: A
authors.initials: A
authors.lastname: Bonadona
authors.forename: P
authors.initials: P
authors.lastname: Morand
mesh_terms: D006561:Herpes Simplex / Q000276:immunology* / Q000517:prevention & control*; D006801:Humans; D019444:Vaccines, DNA / Q000627:therapeutic use; D014765:Viral Vaccines / Q000627:therapeutic use
chemical_list: D019444:Vaccines, DNA; D014765:Viral Vaccines